Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons

Lade...
Vorschaubild
Dateien
Zu diesem Dokument gibt es keine Dateien.
Datum
2023
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Antioxidants. MDPI. 2023, 12(1), 164. eISSN 2076-3921. Available under: doi: 10.3390/antiox12010164
Zusammenfassung

Proteasome inhibition is associated with parkinsonian pathology in vivo and degeneration of dopaminergic neurons in vitro. We explored here the metabolome (386 metabolites) and transcriptome (3257 transcripts) regulations of human LUHMES neurons, following exposure to MG-132 [100 nM]. This proteasome inhibitor killed cells within 24 h but did not reduce viability for 12 h. Overall, 206 metabolites were changed in live neurons. The early (3 h) metabolome changes suggested a compromised energy metabolism. For instance, AMP, NADH and lactate were up-regulated, while glycolytic and citric acid cycle intermediates were down-regulated. At later time points, glutathione-related metabolites were up-regulated, most likely by an early oxidative stress response and activation of NRF2/ATF4 target genes. The transcriptome pattern confirmed proteostatic stress (fast up-regulation of proteasome subunits) and also suggested the progressive activation of additional stress response pathways. The early ones (e.g., HIF-1, NF-kB, HSF-1) can be considered a cytoprotective cellular counter-regulation, which maintained cell viability. For instance, a very strong up-regulation of AIFM2 (=FSP1) may have prevented fast ferroptotic death. For most of the initial period, a definite life–death decision was not taken, as neurons could be rescued for at least 10 h after the start of proteasome inhibition. Late responses involved p53 activation and catabolic processes such as a loss of pyrimidine synthesis intermediates. We interpret this as a phase of co-occurrence of protective and maladaptive cellular changes. Altogether, this combined metabolomics–transcriptomics analysis informs on responses triggered in neurons by proteasome dysfunction that may be targeted by novel therapeutic intervention in Parkinson’s disease.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
proteasome inhibition; neurotoxicity; TempO-Seq; transcriptomics; metabolomics; proteostasis; Nrf2; oxidative stress; ATF4; LUHMES
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690SUCIU, Ilinca, Johannes DELP, Simon GUTBIER, Anna-Katharina ÜCKERT, Anna-Sophie SPRENG, Christiaan KARREMAN, Falk SCHREIBER, Ivana CELARDO, Ivano AMELIO, Marcel LEIST, 2023. Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons. In: Antioxidants. MDPI. 2023, 12(1), 164. eISSN 2076-3921. Available under: doi: 10.3390/antiox12010164
BibTex
@article{Suciu2023-01-10Dynam-59722,
  year={2023},
  doi={10.3390/antiox12010164},
  title={Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons},
  number={1},
  volume={12},
  journal={Antioxidants},
  author={Suciu, Ilinca and Delp, Johannes and Gutbier, Simon and Ückert, Anna-Katharina and Spreng, Anna-Sophie and Karreman, Christiaan and Schreiber, Falk and Celardo, Ivana and Amelio, Ivano and Leist, Marcel},
  note={Article Number: 164}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/59722">
    <dc:contributor>Amelio, Ivano</dc:contributor>
    <dc:creator>Gutbier, Simon</dc:creator>
    <dc:creator>Celardo, Ivana</dc:creator>
    <dc:contributor>Schreiber, Falk</dc:contributor>
    <dc:creator>Delp, Johannes</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/59722"/>
    <dc:creator>Spreng, Anna-Sophie</dc:creator>
    <dc:contributor>Ückert, Anna-Katharina</dc:contributor>
    <dc:creator>Suciu, Ilinca</dc:creator>
    <dc:contributor>Spreng, Anna-Sophie</dc:contributor>
    <dc:creator>Schreiber, Falk</dc:creator>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:contributor>Gutbier, Simon</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Leist, Marcel</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/36"/>
    <dc:language>eng</dc:language>
    <dc:creator>Ückert, Anna-Katharina</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/59722/1/Suciu_2-12ltm8934at0b4.pdf"/>
    <dc:creator>Karreman, Christiaan</dc:creator>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/36"/>
    <dc:contributor>Suciu, Ilinca</dc:contributor>
    <dc:contributor>Delp, Johannes</dc:contributor>
    <dcterms:title>Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons</dcterms:title>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-01-16T08:57:02Z</dcterms:available>
    <dc:contributor>Karreman, Christiaan</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/59722/1/Suciu_2-12ltm8934at0b4.pdf"/>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dc:creator>Leist, Marcel</dc:creator>
    <dcterms:issued>2023-01-10</dcterms:issued>
    <dc:contributor>Celardo, Ivana</dc:contributor>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-01-16T08:57:02Z</dc:date>
    <dcterms:abstract xml:lang="eng">Proteasome inhibition is associated with parkinsonian pathology in vivo and degeneration of dopaminergic neurons in vitro. We explored here the metabolome (386 metabolites) and transcriptome (3257 transcripts) regulations of human LUHMES neurons, following exposure to MG-132 [100 nM]. This proteasome inhibitor killed cells within 24 h but did not reduce viability for 12 h. Overall, 206 metabolites were changed in live neurons. The early (3 h) metabolome changes suggested a compromised energy metabolism. For instance, AMP, NADH and lactate were up-regulated, while glycolytic and citric acid cycle intermediates were down-regulated. At later time points, glutathione-related metabolites were up-regulated, most likely by an early oxidative stress response and activation of NRF2/ATF4 target genes. The transcriptome pattern confirmed proteostatic stress (fast up-regulation of proteasome subunits) and also suggested the progressive activation of additional stress response pathways. The early ones (e.g., HIF-1, NF-kB, HSF-1) can be considered a cytoprotective cellular counter-regulation, which maintained cell viability. For instance, a very strong up-regulation of AIFM2 (=FSP1) may have prevented fast ferroptotic death. For most of the initial period, a definite life–death decision was not taken, as neurons could be rescued for at least 10 h after the start of proteasome inhibition. Late responses involved p53 activation and catabolic processes such as a loss of pyrimidine synthesis intermediates. We interpret this as a phase of co-occurrence of protective and maladaptive cellular changes. Altogether, this combined metabolomics–transcriptomics analysis informs on responses triggered in neurons by proteasome dysfunction that may be targeted by novel therapeutic intervention in Parkinson’s disease.</dcterms:abstract>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen